Pixelgen Technologies

Raised $15.5M in a Series B round, announced 20 August 2026.

Round

Pixelgen Technologies closed an oversubscribed Series B to accelerate global commercialization of its Proxiome Kit, expand into key markets and grow its team and product portfolio.

Amount
$15.5M
Stage
Series B
Announced
20 August 2026
Lead
Flat Capital
Other investors
Industrifonden, Navigare Ventures
Use of funds
Accelerate global commercialization of its Proxiome Kit and expand the company's presence in key markets.
Checked
Announced by the company

Company

Develops tools for mapping molecular cell architecture at nanoscale resolution

Based in
Stockholm, Sweden
Sector
Other
Website
pixelgen.com ↗

Founder

  • Simon FredrikssonCEO and co-Founder

Sources and links

Sources
Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global Expansion prnewswire.com
Stockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteins eu-startups.com
Website
pixelgen.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost